Potential for statins in the chemoprevention and management of hepatocellular carcinoma
出版年份 2012 全文链接
标题
Potential for statins in the chemoprevention and management of hepatocellular carcinoma
作者
关键词
-
出版物
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 27, Issue 11, Pages 1654-1664
出版商
Wiley
发表日期
2012-07-31
DOI
10.1111/j.1440-1746.2012.07232.x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Combined Inhibitory Effects of Celecoxib and Fluvastatin on the Growth of Human Hepatocellular Carcinoma Xenografts in Nude Mice
- (2013) J Gao et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Hepatocarcinogenesis and Ceramide/Cholesterol Metabolism
- (2012) Albert Morales et al. Anti-Cancer Agents in Medicinal Chemistry
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
- (2012) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/dbobese mice
- (2011) Masahito Shimizu et al. BMC CANCER
- Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study
- (2011) W-P Koh et al. BRITISH JOURNAL OF CANCER
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference
- (2011) G.B. John Mancini et al. CANADIAN JOURNAL OF CARDIOLOGY
- MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
- (2011) Z. Cao et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Geraniol and simvastatin show a synergistic effect on a human hepatocarcinoma cell line
- (2011) M. P. Polo et al. CELL BIOCHEMISTRY AND FUNCTION
- Coffee and its Consumption: Benefits and Risks
- (2011) Masood Sadiq Butt et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease
- (2011) Giovanni Musso et al. CURRENT OPINION IN LIPIDOLOGY
- Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database
- (2011) Tania M. Welzel et al. HEPATOLOGY
- Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
- (2011) Wegene Borena et al. INTERNATIONAL JOURNAL OF CANCER
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: A cross-sectional study
- (2011) Jinyan Zhao et al. Nutrition Journal
- Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma
- (2011) Annemilaï Tijeras-Raballand et al. Gastroenterology Research and Practice
- Statin Use and the Risk of Liver Cancer: A Population-Based Case–Control Study
- (2010) Hui-Fen Chiu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells
- (2010) Michihisa Jougasaki et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibition of Autophagy Enhances Anticancer Effects of Atorvastatin in Digestive Malignancies
- (2010) P.-M. Yang et al. CANCER RESEARCH
- IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-Induced STAT3 phosphorylation in human hepatocellular cancer cells
- (2010) Yan Liu et al. CELL CYCLE
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver
- (2010) J. Gracia-Sancho et al. GUT
- Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
- (2010) Judith Ertle et al. INTERNATIONAL JOURNAL OF CANCER
- Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK
- (2010) Relja INTERNATIONAL JOURNAL OF ONCOLOGY
- Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures
- (2010) Harald Loppnow et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension
- (2010) Jaume Bosch et al. JOURNAL OF HEPATOLOGY
- Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values
- (2010) Takashi Kumada et al. JOURNAL OF MEDICAL VIROLOGY
- A historical perspective on the discovery of statins
- (2010) Akira ENDO PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Two Decades of Advances in Hepatocellular Carcinoma Research
- (2010) Jordi Bruix et al. SEMINARS IN LIVER DISEASE
- Statins inhibit the growth of variant human embryonic stem cells and cancer cellsin vitrobut not normal human embryonic stem cells
- (2009) K Gauthaman et al. BRITISH JOURNAL OF PHARMACOLOGY
- Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
- (2009) Juan G. Abraldes et al. GASTROENTEROLOGY
- Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
- (2009) Hashem B. El–Serag et al. GASTROENTEROLOGY
- Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis
- (2009) Valérie Paradis et al. HEPATOLOGY
- Statins, stem cells, and cancer
- (2009) Kalamegam Gauthaman et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis
- (2009) Cristina Ripoll et al. JOURNAL OF HEPATOLOGY
- Interleukin-6 Polymorphisms and Gender: Relationship with the Occurrence of Hepatocellular Carcinoma in Patients with End-Stage Liver Disease
- (2009) Edmondo Falleti et al. ONCOLOGY
- Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma
- (2009) S. Abel et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Transient and etiology-related transcription regulation in cirrhosis prior to hepatocellular carcinoma occurrence
- (2009) Frédérique Caillot et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma
- (2008) Won Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma
- (2008) Z.-B. Ding et al. CANCER RESEARCH
- Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma
- (2008) J. Montero et al. CANCER RESEARCH
- Inhibition of Invasion and Metastasis of Hepatocellular Carcinoma Cells via Targeting RhoC In vitro and In vivo
- (2008) W. Wang et al. CLINICAL CANCER RESEARCH
- STAT 3 as a Target for Cancer Drug Discovery
- (2008) Luca Costantino et al. CURRENT MEDICINAL CHEMISTRY
- Primary prophylaxis of variceal bleeding in cirrhotic patients: A cohort study
- (2008) A. Dell’Era et al. DIGESTIVE AND LIVER DISEASE
- Statins in liver disease: A molehill, an iceberg, or neither?
- (2008) Curtis K. Argo et al. HEPATOLOGY
- Signal Transducer and Activator of Transcription-3: A Molecular Hub for Signaling Pathways in Gliomas
- (2008) E. C. Brantley et al. MOLECULAR CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started